https://imidazoline-receptor.c....om/index.php/the-act
The information of 88 clients with all the very first peritoneal recurrence of platinum-sensitive epithelial ovarian cancer who underwent CRS and HIPEC from a potential HIPEC registry were retrospectively examined. Endpoints had been feasibility, chemotherapeutic chemical, period of exposure, problems, and overall success. The median followup ended up being 4.7 years (95%-CI 4.6-5.5). The median age ended up being 55.8 many years (IQR 50.3-66.2). Eighty-f
Like
Comment
Share
